452
On 26th of January 2006 a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 345. The active ingredient is Lentiviral vector containing the human Wiskott-Aldrich syndrome protein gene for treatment of Wiskott-Aldrich syndrome.